TABLE 4.
Common targets shared between the potential anlotinib targets and lung fibrosis-related targets.
| Number | Gene | Number | Gene |
|---|---|---|---|
| 1 | AXL | 38 | EPHA3 |
| 2 | MERTK | 39 | TIE1 |
| 3 | ERBB2 | 40 | CACNA2D1 |
| 4 | AURKB | 41 | ERBB4 |
| 5 | FLT1 | 42 | MAP3K8 |
| 6 | EGFR | 43 | ERN1 |
| 7 | KDR | 44 | MST1R |
| 8 | SRC | 45 | FGFR4 |
| 9 | MET | 46 | EPHA7 |
| 10 | RET | 47 | MAP2K5 |
| 11 | ALK | 48 | RIPK2 |
| 12 | ABL1 | 49 | DDR2 |
| 13 | KIT | 50 | ACVR1B |
| 14 | ACVR1 | 51 | DDR1 |
| 15 | FLT4 | 52 | MAP4K2 |
| 16 | FLT3 | 53 | EPHA1 |
| 17 | PDGFRA | 54 | EPHB6 |
| 18 | FGFR1 | 55 | ERBB3 |
| 19 | TGFBR1 | 56 | EIF2AK1 |
| 20 | BTK | 57 | MAP3K19 |
| 21 | LYN | 58 | AKT2 |
| 22 | FGFR3 | 59 | PRKCG |
| 23 | PDGFRB | 60 | AKT3 |
| 24 | YES1 | 61 | PIM1 |
| 25 | FGFR2 | 62 | PIM2 |
| 26 | FGR | 63 | JAK1 |
| 27 | CSF1R | 64 | DPP8 |
| 28 | BLK | 65 | DPP9 |
| 29 | PLK4 | 66 | PDE4B |
| 30 | FYN | 67 | PRKCI |
| 31 | MAP2K2 | 68 | CDK2 |
| 32 | HCK | 69 | CDK1 |
| 33 | STK10 | 70 | CCNT1 |
| 34 | ABL2 | 71 | TERT |
| 35 | TEK | 72 | SLC8A1 |
| 36 | SLK | 73 | GNRHR |
| 37 | STK4 | 74 | AOC3 |